Quintara Bio is a Contract Manufacturing Organisation (CMO) and Contract Development and Manufacturing Organisation (CDMO) that serves the pharmaceutical industry as a leading supplier of oligonucleotides and plasmids. The company provides pre-clinical oligonucleotides synthesized on the Dr. Oligo 192 platform, delivering sequence-verified, endotoxin-free circular single-stranded DNA (cssDNA) at microgram scale, with lengths ranging from 200nt to 10kb. Quintara Bio also offers a range of complementary services that support various stages of drug development and research.

Services include:
– Oligo synthesis
– Circular single-stranded DNA synthesis
– Next Generation Sequencing (NGS)
– Sanger sequencing
– Cloning services
– DNA prep services

Quintara Bio is committed to providing high-quality products and services tailored to meet the specific needs of their clients in the pharmaceutical sector. For more information, please visit quintarabio.com.